Adherent with FOBT vs no screening |
Age, year | 1.02 (1.02–1.03) |
Male sex | 1.44 (1.31–1.58) |
Charlson Comorbidity Index | 1.0 (ref)b |
0 | 0.78 (0.68–0.88) |
1 | 0.93 (0.76–1.13) |
2 | 0.53 (0.40–0.69) |
≥3 | |
No. of primary care visits (2002–2003) | 1.01 (1.00–1.02) |
No. of non–primary care visits (2002–2003) | 1.00 (0.99–1.01) |
Preventive health examination (PHE) during observation period (2002–2003) | 11.16 (9.61–12.96) |
Adherent with CRC tests other than FOBT vs no screening |
Age, year | 0.98 (0.97–0.99) |
Male sex | 1.03 (0.88–1.21) |
Charlson Comorbidity Index | 1.0 (ref)b |
0 | 0.80 (0.65–1.00) |
1 | 0.68 (0.50–0.92) |
2 | 0.63 (0.42–0.96) |
≥3 | |
No. of primary care visits (2002–2003) | 1.01 (1.00–1.02) |
No. of non–primary care visits (2002–2003) | 1.02 (1.01–1.03) |
PHE during observation period (2002–2003) | 2.36 (2.02–2.75) |